Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
  1. 4 Shares withheld for taxes VP of Research & Development gave up 97 shares (to pay taxes)
  2. 4 Shares withheld for taxes VP of Engineering gave up 97 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 97 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 95 shares (to pay taxes)
  5. 4 Shares withheld for taxes President and CEO gave up 615 shares (to pay taxes)
  6. 4 Shares withheld for taxes VP of Engineering gave up 95 shares (to pay taxes)
  7. 4 Shares withheld for taxes VP of Research & Development gave up 92 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 625 shares (to pay taxes)
  9. 4 Shares withheld for taxes VP of Engineering gave up 97 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 97 shares (to pay taxes)
  11. 4 Shares withheld for taxes VP of Research & Development gave up 94 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CEO gave up 627 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 94 shares (to pay taxes)
  14. 4 Shares withheld for taxes VP of Research & Development gave up 94 shares (to pay taxes)
  15. 4 Shares withheld for taxes VP of Engineering gave up 94 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 93 shares (to pay taxes)
  17. 4 Shares withheld for taxes VP of Research & Development gave up 113 shares (to pay taxes)
  18. 4 Shares withheld for taxes VP of Engineering gave up 93 shares (to pay taxes)
  19. 4 Shares withheld for taxes President and CEO gave up 617 shares (to pay taxes)
  20. 4 Shares withheld for taxes VP of Research & Development gave up 122 shares (to pay taxes)

Page 9 of 21 · 406 filings